Evidence map›Paper›PMID 28796783›Full record

ArticlePloS one2017

MyD88 contribution to ocular surface homeostasis.

Rose Y Reins, Justin Courson, Carolina Lema, Rachel L Redfern

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. ThemBio · 2025
    Article
  4. KGF-2 Alleviates Dry Eye Disease by Regulating the HMGB1/TLR4 Pathway.Investigative ophthalmology & visual science · 2025
    Article
  5. Contact Lens Wear Alters Transcriptional Responses tobioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Nerve-associated transient receptor potential ion channels can contribute to intrinsic resistance to bacterial adhesion in vivo.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. MyD88 Deficiency Protects Against Dry Eye-Induced Damage.Investigative ophthalmology & visual science · 2018
    Article
  13. High-Mobility Group Box 1 in Dry Eye Inflammation.Investigative ophthalmology & visual science · 2018
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rose Y ReinsThe Ocular Surface Institute, College of Optometry, University of Houston, Houston, Texas, United States of America.
Justin CoursonThe Ocular Surface Institute, College of Optometry, University of Houston, Houston, Texas, United States of America.
Carolina LemaThe Ocular Surface Institute, College of Optometry, University of Houston, Houston, Texas, United States of America.
Rachel L RedfernThe Ocular Surface Institute, College of Optometry, University of Houston, Houston, Texas, United States of America.
University of Houston · US

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI VALLABH E DAS · 1988 to 2026
$16.4M
Toll-Like Receptor and Dry Eye Inflammation and InfectionR01EY023628 · NEI · UNIVERSITY OF HOUSTON · PI REDFERN, RACHEL LEIGH · 2013 to 2017
$1.9M
NEI NIH HHS P30 EY007551NEI NIH HHS R01 EY023628
6 · The paper itself

Abstract

The cornea must maintain homeostasis, enabling rapid response to injury and microbial insult, to protect the eye from insult and infection. Toll-like receptors (TLRs) are critical to this innate immune response through the recognition and response to pathogens. Myeloid differentiation primary response (MyD88) is a key signaling molecule necessary for Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R)-mediated immune defense and has been shown to be necessary for corneal defense during infection. Here, we examined the intrinsic role of TLR signaling in ocular surface tissues by determining baseline levels of inflammatory mediators, the response to mechanical stimuli, and corneal infection in MyD88-deficient mice (MyD88-/-). In addition, cytokine, chemokine, and matrix metalloproteinase (MMP) expression was determined in ocular surface cells exposed to a panel of TLR agonists. Compared to wild-type (WT) animals, MyD88-/- mice expressed lower MMP-9 levels in the cornea and conjunctiva. Corneal IL-1α, TNFα, and conjunctival IL-1α, IL-2, IL-6, and IL-9 levels were also significantly reduced. Additionally, CXCL1 and RANTES expression was lower in both MyD88-/- tissues compared to WT and IL-1R-/- mice. Interestingly, MyD88-/- mice had lower corneal sensitivities (1.01±0.31 gm/mm2) than both WT (0.59±0.16 gm/mm2) and IL-1R-/- (0.52±0.08 gm/mm2). Following Pseudomonas aeruginosa challenge, MyD88-/- mice had better clinical scores (0.5±0.0) compared to IL-1R-/- (1.5±0.6) and WT (2.3±0.3) animals, but had significantly more corneal bacterial isolates. However, no signs of infection were detected in inoculated uninjured corneas from either MyD88 or IL-1R-deficient mice. This work furthers our understanding of the importance of TLR signaling in corneal defense and immune homeostasis, showing that a lack of MyD88 may compromise the baseline innate response to insult.

Indexed as

AnimalsChemokine CCL5Chemokine CXCL1ConjunctivaCorneaCytokinesMatrix Metalloproteinase 9MiceMice, KnockoutMyeloid Differentiation Factor 88Chemokine CCL5Chemokine CXCL1CytokinesMatrix Metalloproteinase 9Myd88 protein, mouseMyeloid Differentiation Factor 88

Identifiers

PMID28796783
PMCPMC5552092
OpenAlexW2744215906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.